Predictions
BeiGene Ltd ADR
Start price
Target price
Perf. (%)
€138.00
06.02.24
06.02.24
€172.29
06.02.25
06.02.25
30.43%
29.08.24
29.08.24
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.51
06.02.24
06.02.24
€2.79
06.02.25
06.02.25
50.77%
02.09.24
02.09.24
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€405.00
06.02.24
06.02.24
€425.79
06.02.25
06.02.25
10.65%
02.09.24
02.09.24
Bayer AG ADR
Start price
Target price
Perf. (%)
€7.25
06.02.24
06.02.24
€7.00
06.02.25
06.02.25
-4.45%
30.08.24
30.08.24
EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.25
05.02.24
05.02.24
€27.00
05.02.25
05.02.25
50.95%
02.09.24
02.09.24
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.35
05.02.24
05.02.24
-
05.02.25
05.02.25
29.34%
06.02.24
06.02.24
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€117.60
05.02.24
05.02.24
€125.66
05.02.25
05.02.25
-7.12%
02.09.24
02.09.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€868.50
05.02.24
05.02.24
€1,034.6
05.02.25
05.02.25
23.20%
02.09.24
02.09.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€858.00
05.02.24
05.02.24
€1,006.8
05.02.25
05.02.25
24.71%
02.09.24
02.09.24
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€11.45
05.02.24
05.02.24
€15.82
05.02.25
05.02.25
47.60%
02.09.24
02.09.24
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
05.02.24
05.02.24
-
05.02.25
05.02.25
-41.77%
17.08.24
17.08.24
Risky Investment
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.16
05.02.24
05.02.24
-
05.02.25
05.02.25
-68.30%
17.08.24
17.08.24
Probably not worthwhile Investment
United Therapeutics
Start price
Target price
Perf. (%)
€198.35
05.02.24
05.02.24
€307.26
05.02.25
05.02.25
65.92%
02.09.24
02.09.24
Coherus Bioscien.
Start price
Target price
Perf. (%)
€1.88
05.02.24
05.02.24
-
05.02.25
05.02.25
33.90%
17.02.24
17.02.24
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Fibrogen Inc.
Start price
Target price
Perf. (%)
€1.72
05.02.24
05.02.24
-
05.02.25
05.02.25
24.42%
17.02.24
17.02.24
Very low/no dividend yield expected
Risky Investment
EBIT decline/stagnation expected
High valuation
Atara Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.32
05.02.24
05.02.24
-
05.02.25
05.02.25
-43.81%
08.02.24
08.02.24
Good culture
Risky Investment
No uniques
Anavex Life Sciences Corp
Start price
Target price
Perf. (%)
€5.22
04.02.24
04.02.24
-
04.02.25
04.02.25
3.72%
17.08.24
17.08.24
Risky Investment
Higher risks for its business
High valuation
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€1.13
04.02.24
04.02.24
-
04.02.25
04.02.25
-45.13%
17.08.24
17.08.24
Probably not worthwhile Investment
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.84
04.02.24
04.02.24
€7.00
31.10.25
31.10.25
-66.38%
19.08.24
19.08.24
Could be very worthwhile Investment >20% year